Rankings
▼
Calendar
TLPH Q4 2020 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena
TLPH
Talphera, Inc.
$18M
Q4 2020 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$738,000
+55.4% YoY
Gross Profit
-$1M
-189.4% margin
Operating Income
-$9M
-1252.6% margin
Net Income
-$9M
-1208.4% margin
EPS (Diluted)
$-1.93
QoQ Revenue Growth
-46.1%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$8M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$66M
Total Liabilities
$122M
Stockholders' Equity
-$56M
Cash & Equivalents
$27M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$738,000
$475,000
+55.4%
Gross Profit
-$1M
-$2M
+36.6%
Operating Income
-$9M
-$15M
+38.3%
Net Income
-$9M
-$14M
+38.2%
← FY 2020
All Quarters
Q1 2021 →